Option Care Health (OPCH) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
27 May, 2026Purpose and mission
Aims to provide extraordinary care that changes lives and transform healthcare through innovative services that improve outcomes, reduce costs, and deliver hope for patients and families.
Market position and scale
Serves over 315,000 patients annually with more than 5,000 clinicians and 190+ U.S. locations.
Operates 90+ full-service pharmacies and 750+ infusion chairs, licensed in all 50 states.
In-network with top 10 payers, covering 96% of insured lives.
Industry trends and growth drivers
U.S. home infusion industry projected to grow at high single-digit rates, driven by therapy growth, cost pressures, and patient preference for aging in place.
Shifts toward cost-effective home and alternate site care models, with payor pressure and pharmaceutical innovation fueling demand.
Latest events from Option Care Health
- All proposals passed with strong support amid solid growth and ongoing industry challenges.OPCH
AGM 202621 May 2026 - Q1 disruption cut revenue guidance, but cost controls and investments support long-term growth.OPCH
Bank of America Global Healthcare Conference 202613 May 2026 - Q1 2026 revenue up 1.3%, but chronic headwinds drove net income and margin declines.OPCH
Q1 20264 May 2026 - 2025 revenue rose 13% to $5.65B; 2026 guidance signals further growth despite headwinds.OPCH
Q4 202513 Apr 2026 - 2025 saw double-digit revenue growth, governance enhancements, and strong say-on-pay support.OPCH
Proxy filing8 Apr 2026 - Virtual annual meeting to elect nine directors, ratify auditor, and vote on executive pay.OPCH
Proxy filing8 Apr 2026 - 2026 faces a $25M-$35M headwind amid strong growth, portfolio expansion, and operational investments.OPCH
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Strong growth, diversified revenue, and tech-driven expansion drive robust performance.OPCH
Investor presentation25 Feb 2026 - Q3 2025 revenue up 12.2%, adjusted EPS rose, net income fell, and guidance was raised.OPCH
Q3 202525 Feb 2026